NCT07476300

Brief Summary

The goal of this pilot study is to evaluate the feasibility and preliminary effectiveness of a brief auricular acupuncture program delivered by mental health nurses as a complementary therapy for adults hospitalized with borderline personality disorder (BPD). The main questions it aims to answer are:

  • Is participation in the five-session auricular acupuncture program feasible (in terms of attendance) for hospitalized adults with borderline personality disorder?
  • Does the auricular acupuncture intervention show potential benefits on emotional regulation, anxiety, sleep quality, and overall clinical status? 15 hospitalized adults with BPD will receive 5 individual ear acupuncture sessions, over a 9-day period, based on the National Acupuncture Detoxification Association (N.A.D.A.) protocol in addition to treatment as usual. Participants will complete brief questionnaires at several time points. The findings will inform the feasibility of the study procedures and guide the development of a future larger-scale clinical trial.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
15

participants targeted

Target at below P25 for not_applicable

Timeline
4mo left

Started Apr 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress28%
Apr 2026Sep 2026

First Submitted

Initial submission to the registry

February 24, 2026

Completed
21 days until next milestone

First Posted

Study publicly available on registry

March 17, 2026

Completed
29 days until next milestone

Study Start

First participant enrolled

April 15, 2026

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 31, 2026

Expected
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2026

Last Updated

March 17, 2026

Status Verified

March 1, 2026

Enrollment Period

4 months

First QC Date

February 24, 2026

Last Update Submit

March 11, 2026

Conditions

Keywords

Borderline Personality DisorderAcupunctureComplementary and Alternative MedicinePsychiatric patientsHospitalized patientsFeasibility StudyPilot studyMental Health Nursing

Outcome Measures

Primary Outcomes (1)

  • Feasibility of the study design

    The primary objective is to evaluate the feasibility of the study design, defined as the attendance to the ear acupuncture sessions (n, %). Feasibility will be deemed satisfactory if 75% of the participants attend at least 4 out of 5 of the planned acupuncture sessions. A proportion lower than 75% will be considered unsatisfactory.

    Participant attendance will be recorded at each scheduled study visit corresponding to acupuncture sessions (Day 0 [baseline], Days 2, 4, 6, and 8) in a study worksheet completed by the nurse administering the intervention.

Secondary Outcomes (9)

  • Impulsive aggression

    Collected at 10 time points: Day 0 (baseline incl. acupuncture n°1); Days 2, 4, 6, and 8 (acupuncture sessions n°2 to 5); Days 1, 3, 5, and 7 (24-hour intervals between sessions); and Day 11 (follow-up, 2 days after program completion).

  • Anxiety

    Collected at 10 time points: Day 0 (baseline incl. acupuncture n°1); Days 2, 4, 6, and 8 (acupuncture sessions n°2 to 5); Days 1, 3, 5, and 7 (24-hour intervals between sessions); and Day 11 (follow-up, 2 days after program completion).

  • Deliberate self-harm

    Collected at 10 time points: Day 0 (baseline incl. acupuncture n°1); Days 2, 4, 6, and 8 (acupuncture sessions n°2 to 5); Days 1, 3, 5, and 7 (24-hour intervals between sessions); and Day 11 (follow-up, 2 days after program completion).

  • Relaxation state

    Collected at 6 time points: Day 0 (baseline incl. acupuncture n°1); Days 2, 4, 6, and 8 (acupuncture sessions n°2 to 5); and Day 11 (follow-up, 2 days after program completion).

  • Sleep quality

    Collected at 10 time points: Day 0 (baseline incl. acupuncture n°1); Days 2, 4, 6, and 8 (acupuncture sessions n°2 to 5); Days 1, 3, 5, and 7 (24-hour intervals between sessions); and Day 11 (follow-up, 2 days after program completion).

  • +4 more secondary outcomes

Study Arms (1)

Auricular acupuncture

EXPERIMENTAL

Single-arm intervention consisting of five individual auricular acupuncture sessions based on the National Acupuncture Detoxification Association (N.A.D.A) protocol, delivered by trained mental health nurses in addition to treatment as usual.

Procedure: Auricular acupuncture program based on the N.A.D.A. protocol

Interventions

Participants receive a brief, standardized auricular acupuncture intervention based on the National Acupuncture Detoxification Association (N.A.D.A.) protocol. The intervention consists of five individual ear acupuncture sessions delivered over nine days, with approximately 24 hours between sessions. Sessions are conducted in the participant's hospital room between 4:00 p.m. and 8:00 p.m. by mental health nurses certified as N.A.D.A. practitioners. Sterile, single-use needles are inserted at three to five standardized auricular points and retained for approximately 30 to 45 minutes. All participants continue to receive treatment as usual throughout the study period. Participants may pause or discontinue the intervention at any time without consequences.

Auricular acupuncture

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Aged 18 years or older
  • Currently hospitalized in a psychiatric unit at the Prangins site of Lausanne University Hospital (CHUV)
  • Diagnosed with borderline personality disorder, as documented in the medical record
  • Able to speak and understand French
  • Able to communicate verbally
  • Clinically stable enough to participate, as determined by the healthcare team
  • Able to understand the study information and provide written informed consent

You may not qualify if:

  • Presence of severe clinical instability, such as: marked agitation, high risk of suicide, risk of harm to others
  • Inability to provide informed consent (for example, due to impaired judgment or legal protective measures)
  • Currently hospitalized in a seclusion or isolation room
  • Expected discharge from hospital before completion of the five acupuncture sessions
  • Current treatment with anticoagulant (blood-thinning) medications
  • Current treatment with immunosuppressive medications
  • Currently receiving acupuncture treatment for any reason
  • Received acupuncture within the past three months for anxiety, emotional regulation, relaxation, or sleep problems
  • Participation in intensive behavioral therapy programs outside usual care that target similar outcomes
  • Presence of skin lesions, irritation, or infection on the ears
  • Severe fear of needles
  • Inability to remain still during acupuncture sessions

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Psychiatric hospitalization units at the Prangins site of the Lausanne University Hospital (CHUV)

Lausanne, Canton of Vaud, Switzerland

Location

MeSH Terms

Conditions

Borderline Personality Disorder

Condition Hierarchy (Ancestors)

Personality DisordersMental Disorders

Central Study Contacts

Jenny Gentizon, Ph.D

CONTACT

Manuel Simon, MSc

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: A quasi-experimental pilot study using a single arm based on a pretest-posttest design
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Nurse PhD, Principal Investigator, Nurse Researcher with a focus on medication-related problems and Senior Lecturer in advanced practice nursing at the Master's level.

Study Record Dates

First Submitted

February 24, 2026

First Posted

March 17, 2026

Study Start

April 15, 2026

Primary Completion (Estimated)

July 31, 2026

Study Completion (Estimated)

September 1, 2026

Last Updated

March 17, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will not share

Aggregated study results will be made publicly available through scientific publications and presentations. Data handling complies with Swiss data protection regulations.

Locations